April 3, 2024
You are here:  Home  >  Latest news  >  Current Article

Annual report shows tax reform hit Amgen hard


After a $6 billion tax hit, net income at Amgen fell 74 percent in 2017, coming off a fourth quarter in which revenues decreased 3 percent to $5.8 billion and net losses reached $4.26 billion. The Thousand Oaks-based biotech giant also announced that its board of directors increased its share repurchase program by $10 billion,…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.